Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,083 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,083 shares of the firm’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83. Following the sale, the chief accounting officer directly owned 5,025 shares of the company’s stock, valued at approximately $95,525.25. The trade was a 29.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Up 10.5%

Shares of Omada Health stock traded up $1.99 during trading hours on Friday, hitting $20.89. 3,310,497 shares of the company’s stock traded hands, compared to its average volume of 946,807. The stock has a 50 day simple moving average of $16.51 and a 200-day simple moving average of $14.85. The company has a market cap of $1.24 billion and a PE ratio of -77.37. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $78.05 million for the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities research analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On Omada Health

A number of institutional investors have recently made changes to their positions in OMDA. Raymond James Financial Inc. bought a new position in Omada Health during the second quarter worth $32,000. Bellevue Group AG increased its stake in Omada Health by 0.7% during the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares during the last quarter. Quarry LP acquired a new stake in shares of Omada Health during the fourth quarter worth $29,000. Barclays PLC boosted its holdings in shares of Omada Health by 14.6% in the 4th quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after buying an additional 1,888 shares during the period. Finally, TD Waterhouse Canada Inc. bought a new position in Omada Health in the fourth quarter worth about $32,000.

Analyst Ratings Changes

OMDA has been the topic of a number of recent analyst reports. Evercore reaffirmed an “outperform” rating and issued a $20.00 target price on shares of Omada Health in a research report on Friday, May 8th. Wall Street Zen lowered shares of Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Morgan Stanley reaffirmed an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a report on Monday. Citigroup reiterated an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, Barclays raised their price objective on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.